Active Stocks

Fri Apr 17 2026 15:58:18

Eternal share price
252.60 -0.06%

HDFC Bank share price
799.90 0.55%

Tata Steel share price
212.05 0.64%

ITC share price
306.80 1.10%

Reliance Industries share price
1,365.10 1.61%

Business News > Mint Authors > Cynthia Koons

Cynthia Koons

ARTICLES BY CYNTHIA KOONS

Pfizer and Allergan on Monday announced plans to combine in a record $160 billion deal, creating a giant with products ranging from Viagra to Botox and a low-cost tax base on the edge of Western Europe. Photo: Reuters

Coronavirus vaccine: Pfizer starts clinical trials in US

4 min read . 05 May 2020

The billionaire founder of Insys Therapeutics Inc. John Kapoor, exits the federal court house after a bail hearing in Phoenix, Arizona. Photo: Reuters

Opioid billionaire John Kapoor’s indictment opens new window on epidemic

4 min read . 27 Oct 2017

A file photo of Intel CEO Brian Krzanich. Photo: AFP

Intel’s Brian Krzanich becomes third CEO to quit Donald Trump business council

5 min read . 15 Aug 2017

Merck & Co. CEO Ken Frazier (right) listens to US President Donald Trump speak during a meeting with manufacturing CEOs at the White House in Washington, DC, US on 23 February 2017. Photo: Reuters

Donald Trump attacks Merck CEO on Twitter after resignation from council

1 min read . 14 Aug 2017

Pfizer has been relying on new branded treatments, including cancer drugs, to boost revenue, as sales of older medicines have slowed. Photo: Reuters

Pfizer said close to $14 billion deal to acquire Medivation

2 min read . 22 Aug 2016

New York-based Pfizer bought Hospira, which makes generic injectable drugs and devices to deliver them, for about $17 billion in a deal that closed in September. Photo: Bloomberg

Pfizer said to weigh sale of pump unit acquired in Hospira deal

1 min read . 14 Jan 2016

Mylan offered $75 in cash and 2.3 Mylan shares for each Perrigo share, a bid that Dublin-based Perrigo had rejected as inadequate. Photo: Bloomberg

Mylan left behind in pharma deal wave as Perrigo attempt fails

3 min read . 14 Nov 2015

Like its competitors, Pfizer has been raising prices on older drugs in its portfolio for years. The increases in the US have added $1.07 billion of quarterly revenue from mid-2012 to the middle of this year. Photo: Bloomberg

Pfizer raised prices on 133 drugs this year, and it’s not alone

4 min read . 06 Oct 2015

Teva bid for Mylan sparks worries of rising generic drug prices

3 min read . 23 Apr 2015

If successful, Mylan’s takeover would add to a record period of consolidation in the pharmaceutical industry. Photo: Getty Images/AFP

Mylan offers to buy drugmaker Perrigo for $28.9 billion

1 min read . 08 Apr 2015

New York-based Pfizer led its peers by a wide margin, spending $751.9 million on television ads, more than double second-biggest spender AbbVie Inc. Photo: AFP

Viagra ads put Pfizer on top of drug industry’s promotion boom

2 min read . 30 Mar 2015

The financial terms of J&J’s pact with Google were not disclosed.

J&J and Google to jointly develop robot-assisted surgery programme

1 min read . 27 Mar 2015

Companies have shown US insurers will routinely pay prices two or three times median household income if the drug is proven to extend life or slow the course of cancer. Photo: Bloomberg (Bloomberg)

Investors warm to $100,000 cancer drugs after $21 billion deal

5 min read . 09 Mar 2015

Doctors are forced to rely on decades-old medicines with sometimes heavy side effects to treat everything from urinary tract infections to deadly hospital-acquired bacteria. Photo: Reuters

Superbug spread reveals thin pipeline of newest antibiotics

3 min read . 20 Feb 2015

Under the strategy called inversion, US companies use mergers to shift their legal address to a lower-tax country without moving their operations. Photo: AFP

Tax rules wouldn’t stop Pfizer from potential overseas move

4 min read . 29 Oct 2014

Without an acquisition, Pfizer will have almost no revenue growth from its dwindling stable of patent-protected drugs, according to analysts’ estimates. Photo: AFP

Pfizer announces it will buy back $11 billion in shares

1 min read . 24 Oct 2014